Skip to content

Radiesse Lidocaine

by Univerderm

Radiesse Lidocaine is a dermal tissue reconstructive material (FDA Class III; FDA product code LMH, Implant, Dermal, For Aesthetic Use) made by Univerderm, approved under FDA PMA P050052 on 22 Dec 2006 and listed in FDA GUDID since 2 Dec 2024 (UDI-DI 03770034301103), active as of 23 Oct 2026. 3 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None ongoing

3 closed

Documents

PMA P050052

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number03770034301103 UDI-DI Date2 Dec 2024ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP050052 Date22 Dec 2006DecidedStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA PMA P050052 decided 22 Dec 2006 Active
  • FDA GUDID UDI-DI 03770034301103 listed 2 Dec 2024 Listed

Recalls

3 recalls · FDA

    • Terminated Z-2607-2016 FDA Class II initiated 20 May 2016

    Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.

    • Terminated Z-0145-2012 FDA Unclassified (pre-2012) initiated 18 Aug 2011

    There is a potential leakage of product that may occur with Merz Aesthetics 1.5cc syringes of Radiesse Dermal Filler. When using the syringe, Health Care Professionals should be alerted to the potential for product that my leak pass the plunger at the proximal end of the syring. The defect may result in infection requiring medical intervention to prevent impairment or damage. To date Merz has n

    • Terminated Z-2221-2011 FDA Unclassified (pre-2012) initiated 6 Apr 2011

    Merz Aesthetics, Inc. is recalling 1 lot (1034417) of Radiesse 1.3 cc Implant. The lot was supposed to be scrapped because it had failed to meet its Loss On Drying (LOD) specification. Unfortunately it had been marked as approved, released and shipped.

Timeline

5 dated events

  1. Approved FDA PMA P050052
  2. Recall initiated FDA recalls Z-2221-2011
  3. Recall initiated FDA recalls Z-0145-2012
  4. Recall initiated FDA recalls Z-2607-2016
  5. Listed FDA GUDID 03770034301103

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Radiesse
Generic name
Dermal tissue reconstructive material, microbe-derived, anaesthetic
Model / reference
Lidocaine
Primary DI / UDI-DI
03770034301103
PMA number
FDA product code
LMH
GMDN term
Dermal tissue reconstructive material, microbe-derived, anaesthetic
Device class
Class III
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code LMH (Implant, Dermal, For Aesthetic Use).

Other devices from Univerderm

See all devices from Univerderm →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)